Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study

Introduction: To analyze the feasibility and efficacy of sleeve lobectomy after neoadjuvant immunotherapy in multicenter patients with squamous cell lung cancer. Methods: We retrospectively identified patients who received neoadjuvant immunotherapy (n = 14) or chemotherapy alone (n = 33) at five tho...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	JTO Clinical and Research Reports
المؤلفون الرئيسيون:	Tianxiang Chen, MD, PhD, Junwei Ning, MD, Jianfei Shen, MD, PhD, Hui Pan, MD, Linhai Fu, MD, Enwu Xu, MD, PhD, Han Wu, MD, Jia Huang, MD, PhD, Yunhai Yang, MD, PhD, Ziming Li, MD, PhD, Qingquan Luo, MD, PhD
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2023-04-01
الموضوعات:	Neoadjuvant therapy Sleeve lobectomy Squamous cell lung cancer PD-1 inhibitor
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2666364323000115